Human papillomavirus testing using HPV APTIMA® assay and an external cellularity control in self‐collected samples
- 13 December 2023
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 95 (12) , e29283
Abstract
In cervical cancer screening programs, the detection of high‐risk human papillomavirus (HR‐HPV) is now widely implemented on physician‐collected samples and has expanded to include self‐collected samples. The use of a cellularity control (CC) is needed to reduce false‐negative HPV results. An external mRNA CC for the HPV APTIMA® assay was assessed for its analytical performance and the results were compared with both cervix cytobrush samples taken by physicians and self‐collected vaginal samples from 148 women. The performance of the CC was adjusted to control for the presence of cellular mRNA in the ThinPrep® and Multitest® transport media. This CC is user‐friendly but implies to perform two independent assays on PANTHER® automate. Self‐collected vaginal sampling gives a lower median CC results (13.2 vs. 16.9 min) but a higher risk of negative CC results (3.3 vs. 0%). The usefulness of the CC for the HR‐HPV assay may be optimized by the definition of a threshold for a minimum cell number to be tested to increase confidence in HPV‐negative results. The systematic use of an RNA CC increases confidence for HPV RNA assays on self‐collected vaginal samples.Keywords
This publication has 25 references indexed in Scilit:
- High Human Papillomavirus DNA loads in Inflammatory Middle Ear DiseasesPathogens, 2020
- Increased HPV detection by the use of a pre-heating step on vaginal self-samples analysed by Aptima HPV assayJournal of Virological Methods, 2019
- Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assayJournal of Virological Methods, 2019
- Comparison of CerviHPV and Hybrid Capture 2 HPV tests for detection of high‐risk HPV infection in cervical swab specimensDiagnostic Cytopathology, 2018
- Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analysesBMJ, 2018
- Self-sampling with HPV mRNA analyses from vagina and urine compared with cervical samplesJournal of Clinical Virology, 2018
- Specimen Adequacy2015
- Validation of high-risk HPV tests for primary cervical screeningJournal of Clinical Virology, 2009
- Analytical characterization of the APTIMA® HPV AssayJournal of Clinical Virology, 2009
- Efficiency of the APTIMA® HPV Assay for detection of HPV RNA and DNA targetsJournal of Clinical Virology, 2009